Begins Coverage on Retractable Technologies (NYSE:RVP)

Equities research analysts at assumed coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research note issued on Tuesday. The firm set a “hold” rating on the stock.

Retractable Technologies Trading Up 2.9 %

Shares of Retractable Technologies stock opened at $1.08 on Tuesday. The company has a quick ratio of 8.18, a current ratio of 11.02 and a debt-to-equity ratio of 0.01. The firm has a market cap of $32.34 million, a price-to-earnings ratio of -4.15 and a beta of 2.07. The business has a fifty day simple moving average of $1.07 and a 200-day simple moving average of $1.14. Retractable Technologies has a fifty-two week low of $0.87 and a fifty-two week high of $1.34.

Retractable Technologies (NYSE:RVPGet Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%. The business had revenue of $7.60 million during the quarter.

Insider Activity at Retractable Technologies

In related news, CEO Thomas J. Shaw purchased 48,635 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The stock was acquired at an average price of $1.03 per share, for a total transaction of $50,094.05. Following the transaction, the chief executive officer now directly owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders purchased 143,649 shares of company stock worth $148,926 in the last quarter. 54.60% of the stock is owned by company insiders.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Articles

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with's FREE daily email newsletter.